Most dollars spent on top-selling orphan drugs don’t go to treat people with rare diseases
Srudy shows how tissue’s microscopic geometry affects spread of cancer
1 March 2021Rapid antigen testing for COVID-19: Piecing the puzzle together
1 March 2021Most dollars spent on top-selling orphan drugs don’t go to treat people with rare diseases
For more than 30 years, the U.S. government has encouraged drug companies to develop new treatments for rare diseases that affect fewer than 200,000 Americans, and to see if existing drugs might also be effective for these diseases.
